Kinetics of platelet adhesion to a fibrinogen-coated surface in whole blood under flow conditions.


Journal

Journal of clinical laboratory analysis
ISSN: 1098-2825
Titre abrégé: J Clin Lab Anal
Pays: United States
ID NLM: 8801384

Informations de publication

Date de publication:
Sep 2021
Historique:
revised: 19 07 2021
received: 15 04 2021
accepted: 24 07 2021
pubmed: 5 8 2021
medline: 27 1 2022
entrez: 4 8 2021
Statut: ppublish

Résumé

To test a novel method of assessment of platelet adhesion to a fibrinogen-coated surface in whole blood under flow conditions. We developed a fluidic device that mimics blood flow in vessels. The method of detection of platelet adhesion is based on recording of a scattered laser light signal from a fibrinogen-covered surface. Testing was performed in platelet-rich plasma (PRP) and whole blood of healthy volunteers. Control measurements were performed, followed by tests with inhibition of platelet GPIIa/IIIb and GPIb receptors. Then, the same testing sequence was performed in whole blood of persons with autoimmune thrombocytopenia and type 3 von Willebrand disease. The change in intensity of scattered light was 2.7 (2.4; 4.1) times higher in whole blood (0.2 ± 0.08V, n = 7) than in PRP (0.05 ± 0.02 V, n = 7), p < 0.01. The blocking of GP IIb/IIIa receptors decreased the intensity of scattered light to 8.5 (6.5;12)%; the blocking of GPIb receptors decreased it to 34 (23;58)%, p < 0.01. In the whole blood of a person with autoimmune thrombocytopenia, the inhibition of GPIb receptors decreased platelet adhesion, but no effect was observed in type 3 von Willebrand disease. Inhibition of platelet GPIIb/IIIa receptors alone or combined inhibition of GPIb and GPIIb/IIIa receptors resulted in almost total suppression of adhesion in both cases. Our system effectively registers platelet adhesion to a fibrinogen-coated surface under controlled-flow conditions and may successfully be applied to the investigation of platelet adhesion kinetics.

Identifiants

pubmed: 34347925
doi: 10.1002/jcla.23939
pmc: PMC8418503
doi:

Substances chimiques

Platelet Aggregation Inhibitors 0
Platelet Glycoprotein GPIIb-IIIa Complex 0
Platelet Glycoprotein GPIb-IX Complex 0
Fibrinogen 9001-32-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e23939

Subventions

Organisme : Russian Science Foundation
ID : 21-15-00029

Informations de copyright

© 2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.

Références

Platelets. 2018 Nov;29(7):662-669
pubmed: 29537929
Lab Chip. 2008 Sep;8(9):1486-95
pubmed: 18818803
Clin Lab. 2020 Apr 1;66(4):
pubmed: 32255287
Anal Chem. 2013 Jul 2;85(13):6497-504
pubmed: 23713824
Thromb Res. 2015 Jul;136(1):13-9
pubmed: 26014643
J Biomed Mater Res A. 2005 Jul 1;74(1):69-83
pubmed: 15909286
Platelets. 2017 Jul;28(5):434-440
pubmed: 28580870
Clin Lab. 2020 Mar 1;66(3):
pubmed: 32162891
Blood. 1990 Jul 15;76(2):345-53
pubmed: 2369638
Sci Rep. 2020 Oct 29;10(1):18604
pubmed: 33122712
Blood. 1996 Sep 1;88(5):1525-41
pubmed: 8781407
Proc Natl Acad Sci U S A. 2007 May 8;104(19):7899-903
pubmed: 17470810
Arteriosclerosis. 1988 Nov-Dec;8(6):819-24
pubmed: 3196226
Biophys J. 2016 Feb 2;110(3):669-679
pubmed: 26840731
Blood. 1995 Dec 1;86(11):4158-65
pubmed: 7492773
Biomaterials. 2016 Jul;96:72-83
pubmed: 27156141
Clin Lab. 2021 Jan 1;67(1):
pubmed: 33491415
PLoS One. 2013 Oct 07;8(10):e76243
pubmed: 24116099
J Biomed Mater Res. 2002 Jun 5;60(3):348-59
pubmed: 11920657
Biomaterials. 2000 Nov;21(22):2243-52
pubmed: 11026630
PLoS One. 2017 Sep 18;12(9):e0184941
pubmed: 28922391
Biochemistry. 1988 Jan 26;27(2):633-40
pubmed: 2450575
Annu Rev Biomed Eng. 2017 Jun 21;19:415-433
pubmed: 28441034
J Clin Invest. 1991 Apr;87(4):1234-40
pubmed: 2010539
Biull Eksp Biol Med. 1994 Oct;118(10):402-5
pubmed: 7865820
Lab Chip. 2014 Aug 21;14(16):3043-9
pubmed: 24960122
Bull Exp Biol Med. 2018 May;165(1):157-160
pubmed: 29796802
Biomed Mater. 2012 Aug;7(4):045007
pubmed: 22652380
J Thromb Haemost. 2008 Dec;6(12):2193-201
pubmed: 18983510
J Clin Lab Anal. 2021 Sep;35(9):e23939
pubmed: 34347925

Auteurs

Zufar A Gabbasov (ZA)

National Medical Research Centre for Cardiology of the Ministry of Health of the Russian Federation, Moscow, Russia.

Yuliya N Avtaeva (YN)

National Medical Research Centre for Cardiology of the Ministry of Health of the Russian Federation, Moscow, Russia.

Ivan S Melnikov (IS)

National Medical Research Centre for Cardiology of the Ministry of Health of the Russian Federation, Moscow, Russia.
Institute of Biomedical Problems of Russian Academy of Sciences, Moscow, Russia.

Sergey D Okhota (SD)

National Medical Research Centre for Cardiology of the Ministry of Health of the Russian Federation, Moscow, Russia.

Martin Caprnda (M)

1st Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.

Ioana Mozos (I)

Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
Center for Translational Research and Systems Medicine, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

Robert Prosecky (R)

2nd Department of Internal Medicine, Faculty of Medicine, Masaryk University and St, Anne´s University Hospital, Brno, Czech Republic.

Luis Rodrigo (L)

Faculty of Medicine, University of Oviedo and Central University Hospital of Asturias (HUCA), Oviedo, Spain.

Peter Kruzliak (P)

2nd Department of Surgery, Faculty of Medicine, Masaryk University and St, Anne´s University Hospital, Brno, Czech Republic.

Nadezhda I Zozulya (NI)

National Research Center for Hematology of the Ministry of Health of the Russian Federation, Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH